Vital Images secures stock placement
Minneapolis-based Vital Images has recruited eight accredited institutional investors to purchase 1.5 million shares of common stock at $13.50 per share. The private placement, announced June 2, generated some $19 million after deducting closing costs
Minneapolis-based Vital Images has recruited eight accredited institutional investors to purchase 1.5 million shares of common stock at $13.50 per share. The private placement, announced June 2, generated some $19 million after deducting closing costs and placement fees. U.S. Bancorp Piper Jaffray served as exclusive placement agent for the transaction. Funds will provide the flexibility to expand VI's business through acquisition or other opportunities, according to the company. In weeks prior to the placement, VI stock soared to nearly $18. As of June 5, share price had settled at about $14.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
